L-carnitine ameliorated fasting-induced fatigue, hunger, and metabolic abnormalities in patients with metabolic syndrome: A randomized controlled study

Nutrition Journal

Volumn 13, Issue 1, 2014, Pages

  Zhang, Jun Jie ^a   Wu, Zhi Bing ^b   Cai, You Jin ^a   Ke, Bin ^a   Huang, Ying Juan ^a   Qiu, Chao Ping ^a   Yang, Yu Bing ^a   Shi, Lan Ying ^a   Qin, Jian ^a  

^a THE FIRST AFFILIATED HOSPITAL OF SUN YAT SEN UNIVERSITY   (China)

^b GUANGZHOU UNIVERSITY OF CHINESE MEDICINE   (China)

Author keywords

L carnitine; Metabolic syndrome; Very low calorie diet; Weight loss

Indexed keywords

ALANINE AMINOTRANSFERASE; C REACTIVE PROTEIN; CARNITINE; CHOLESTEROL; FATTY ACID; GAMMA GLUTAMYLTRANSFERASE; HIGH DENSITY LIPOPROTEIN CHOLESTEROL; INSULIN; TRIACYLGLYCEROL; URIC ACID; GLUCOSE BLOOD LEVEL; LOW DENSITY LIPOPROTEIN CHOLESTEROL;

ADULT; AGED; ALANINE AMINOTRANSFERASE BLOOD LEVEL; ANTHROPOMETRY; ARTICLE; BLOOD PRESSURE; BODY MASS; CALORIC RESTRICTION; CHOLESTEROL BLOOD LEVEL; CLINICAL ARTICLE; CLINICAL EVALUATION; CONTROLLED STUDY; DIASTOLIC BLOOD PRESSURE; DIET; DISEASE SEVERITY; EXERCISE; FASTING INDUCED FATIGUE; FATIGUE; FEMALE; GLUCOSE BLOOD LEVEL; HUMAN; HUNGER; HYPERSENSITIVITY; LIVER FUNCTION; MALE; METABOLIC SYNDROME X; RANDOMIZED CONTROLLED TRIAL; SCORING SYSTEM; SELF CONCEPT; SINGLE BLIND PROCEDURE; SYSTOLIC BLOOD PRESSURE; URIC ACID BLOOD LEVEL; VISUAL ANALOG SCALE; WAIST CIRCUMFERENCE; WAIST HIP RATIO; WEIGHT REDUCTION; ADVERSE EFFECTS; BLOOD; DIET RESTRICTION; DRUG EFFECTS; INTRAVENOUS DRUG ADMINISTRATION; METABOLISM; MIDDLE AGED; PILOT STUDY; TREATMENT OUTCOME;

ADMINISTRATION, INTRAVENOUS; ADULT; ALANINE TRANSAMINASE; BLOOD GLUCOSE; BLOOD PRESSURE; BODY MASS INDEX; C-REACTIVE PROTEIN; CARNITINE; CHOLESTEROL, HDL; CHOLESTEROL, LDL; DIET; EXERCISE; FASTING; FATIGUE; FATTY ACIDS, NONESTERIFIED; FEMALE; GAMMA-GLUTAMYLTRANSFERASE; HUMANS; HUNGER; INSULIN; MALE; METABOLIC SYNDROME X; MIDDLE AGED; PILOT PROJECTS; SINGLE-BLIND METHOD; TREATMENT OUTCOME; URIC ACID; WAIST CIRCUMFERENCE; WEIGHT LOSS;

EID: 84964314006     PISSN: None     EISSN: 14752891     Source Type: Journal    
DOI: 10.1186/1475-2891-13-110     Document Type: Article

References (51)

1. Roberts CK, Hevener AL, Barnard RJ: Metabolic syndrome and insulin resistance: underlying causes and modification by exercise training. Compr Physiol 2013, 3:1-58.
2. Xi B, He D, Hu Y, Zhou D: Prevalence of metabolic syndrome and its influencing factors among the Chinese adults: The China Health and Nutrition Survey in 2009. Prev Med 2013, 57(6):867-871.
3. Qin J: Fasting therapy in China: modification and future development. Chin J Integr Med 2013 2013, 19(12):883-884.
4. Michalsen A, Hoffmann B, Moebus S, Bäcker M, Langhorst J, Dobos GJ: Incorporation of fasting therapy in an integrative medicine ward-evaluation of safety and effects on lifestyle adherence in a large prospective cohort study. J Altern Complement Med 2005, 1:601-607.
5. Pekala J, Patkowska-Sokoła B, Bodkowski R, Jamroz D, Nowakowski P, Lochynski S, Librowski T: L-carnitine-metabolic functions and meaning in humans life. Curr Drug Metab 2011, 12(7):667-678.
6. Flanagan JL, Simmons PA, Vehige J, Willcox MD, Garrett Q: Role of carnitine in disease. Nutr Metab (Lond) 2010, 7:30.
7. Cave MC, Hurt RT, Frazier TH, Matheson PJ, Garrison RN, McClain CJ, McClave SA: Obesity, inflammation, and the potential application of pharmaconutrition. Nutr Clin Pract 2008, 23:16-34.
8. Bianchi PB, Lehotay DC, Davis AT: Carnitine supplementation ameliorates the steatosis and ketosis induced by pivalate in rats. J Nutr 1996, 126:2873-2879.
9. Blanchard G, Paragon BM, Milliat F, Lutton C: Dietary L-carnitine supplementation in obese cats alters carnitine metabolism and decreases ketosis during fasting and induced hepatic lipidosis. J Nutr 2002, 132:204-210.
10. Noland RC, Koves TR, Seiler SE, Lum H, Lust RM, Ilkayeva O, Stevens RD, Hegardt FG, Muoio DM: Carnitine insufficiency caused by aging and overnutrition compromises mitochondrial performance and metabolic control. J Biol Chem 2009, 284:22840-22852.
11. Calabrese V, Cornelius C, Dinkova-Kostova AT, Calabrese EJ, Mattson MP: Cellular stress responses, the hormesis paradigm, and vitagenes: novel targets for therapeutic intervention in neurodegenerative disorders. Antioxid Redox Signal 2010, 13:1763-1811.
12. Neri S, Pistone G, Saraceno B, Pennisi G, Luca S, Malaguarnera M: L-carnitine decreases severity and type of fatigue induced by interferon-alpha in the treatment of patients with hepatitis C. Neuropsychobiology 2003, 47:94-97.
13. Rebouche CJ: Kinetics, pharmacokinetics, and regulation of L-carnitine and acetyl-L-carnitine metabolism. Ann N Y Acad Sci 2004, 1033:30-41.
14. Evans AM, Fornasini G: Pharmacokinetics of L-carnitine. Clin Pharmacokinet 2003, 42:941-967.
15. Segre G, Bianchi E, Corsi M, D'Iddio S, Ghirardi O, Maccari F: Plasma and urine pharmacokinetics of free and of short-chain carnitine after administration of carnitine in man. Arzneimittelforschung 1988, 38:1830-1834.
16. Awad S1, Lobo DN: Metabolic conditioning to attenuate the adverse effects of perioperative fasting and improve patient outcomes. Curr Opin Clin Nutr Metab Care 2012, 15(2):194-200.
17. Grundy SM, Cleeman JI, Daniels SR, Donato KA, Eckel RH, Franklin BA, Gordon DJ, Krauss RM, Savage PJ, Smith SC Jr, Spertus JA, Costa F: Diagnosis and management of the metabolic syndrome: an American Heart Association/National Heart, Lung, and Blood Institute Scientific statement. Circulation 2005, 112:2735-2752.
18. Dupont WD, Plummer WD: Power and sample size calculations for studies involving linear regression. Control Clin Trials 1998, 19:589-601.
19. Calloway DH, Calloway CW, Chumlea WC: Circumference. In Anthropometric Standardization Reference Manual. Edited by Lohman TG, Roche AF, Martorell R. Champaign, IL: Human Kinetics; 1988:39-54.
20. Parker BA, Sturm K, MacIntosh CG, Feinle C, Horowitz M, Chapman IM: Relation between food intake and visual analogue scale ratings of appetite and other sensations in healthy older and young subjects. Eur J Clin Nutr 2004, 58:212-218.
21. Wessely S, Powell R: Fatigue syndromes: a comparison of chronic 'postviral' fatigue with neuromuscular and affective disorders. J Neurol Neurosurg Psychiatry 1989, 52:940-948.
22. World Medical Association: World Medical Association Declaration of Helsinki: ethical principles for medical research involving human subjects. J Postgrad Med 2002, 48(3):206-208.
23. Ziaee V, Razaei M, Ahmadinejad Z, Shaikh H, Yousefi R, Yarmohammadi L, Bozorgi F, Behjati MJ: The changes of metabolic profile and weight during Ramadan fasting. Singapore Med J 2006, 47:409-414.
24. Johnstone AM, Murison SD, Duncan JS, Rance KA, Speakman JR: Factors influencing variation in basal metabolic rate include fat-free mass, fat mass, age, and circulating thyroxine but not sex, circulating leptin, or triiodothyronine. Am J Clin Nutr 2005, 82:941-948.
25. Eckel RH, Alberti KG, Grundy SM, Zimmet PZ: The metabolic syndrome. Lancet 2010, 375:181-183.
26. White AM, Johnston CS, Swan PD, Tjonn SL, Sears B: Blood ketones are directly related to fatigue and perceived effort during exercise in overweight adults adhering to low-carbohydrate diets for weight loss: a pilot study. J Am Diet Assoc 2007, 107:1792-1796.
27. O'Connor JE, Costell M, Míguez MP, Portolés M, Grisolía S: Effect of L-carnitine on ketone bodies, redox state and free amino acids in the liver of hyperammonemic mice. Biochem Pharmacol 1987, 36:3169-3173.
28. Power RA, Hulver MW, Zhang JY, Dubois J, Marchand RM, Ilkayeva O, Muoio DM, Mynatt RL: Carnitine revisited: potential use as adjunctive treatment in diabetes. Diabetologia 2007, 50:824-832.
29. Center SA, Harte J, Watrous D, Reynolds A, Watson TD, Markwell PJ: The clinical and metabolic effects of rapid weight loss in obese pet cats and the influence of supplemental oral L-carnitine. J Vet Intern Med 2000, 14:598-608.
30. Center SA, Warner KL, Randolph JF, Sunvold GD, Vickers JR: Influence of dietary supplementation with (L)-carnitine on metabolic rate, fatty acid oxidation, body condition, and weight loss in overweight cats. Am J Vet Res 2012, 2012(73):1002-1015.
31. Molfino A, Cascino A, Conte C, Ramaccini C, Rossi Fanelli F, Laviano A: Caloric restriction and L-carnitine administration improves insulin sensitivity in patients with impaired glucose metabolism. J Parenter Enteral Nutr 2010, 34:295-299.
32. Villani RG, Gannon J, Self M, Rich PA: L-Carnitine supplementation combined with aerobic training does not promote weight loss in moderately obese women. Int J Sport Nutr Exerc Metab 2000, 10:199-207.
33. De Gaetano A, Mingrone G, Castagneto M, Calvani M: Carnitine increases glucose disposal in humans. J Am Coll Nutr 1999, 18:289-295.
34. Mingrone G, Greco AV, Capristo E, Benedetti G, Giancaterini A, De Gaetano A, Gasbarrini G: L-carnitine improves glucose disposal in type 2 diabetic patients. J Am Coll Nutr 1999, 18:77-82.
35. Ferrannini E, Buzzigoli G, Bevilacqua S, Boni C, Del Chiaro D, Oleggini M, Brandi L, Maccari F: Interaction of carnitine with insulin-stimulated glucose metabolism in humans. Am J Physiol 1988, 255:E946-E952.
36. Luci S, Hirche F, Eder K: Fasting and caloric restriction increases mRNA concentrations of novel organic cation transporter-2 and carnitine concentrations in rat tissues. Ann Nutr Metab 2008, 52:58-67.
37. Kerndt PR, Naughton JL, Driscoll CE, Driscoll CE, Loxterkamp DA: Fasting: the history, pathophysiology and complications. West J Med 1982, 137:379-399.
38. Sävendahl L, Underwood LE: Fasting increases serum total cholesterol, LDL cholesterol, and apolipoprotein B in healthy, nonobese humans. J Nutr 1999, 129:2005-2008.
39. Li C, Ostermann T, Hardt M, Lüdtke R, Broecker-Preuss M, Dobos G, Michalsen A: Metabolic and psychological response to 7-day fasting in obese patients with and without metabolic syndrome. Forsch Komplementmed 2013, 20:413-420.
40. Swaner JC, Connor WE: Hypercholesterolemia of total starvation: Its mechanism via tissue mobilization of cholesterol. Am J Physiol 1975, 229:365-369.
41. Salter AM, Fisher SC, Brindley DN: Binding of low-density lipoprotein to monolayer cultures of rat hepatocytes is increased by insulin and decreased by dexamethasone. FEBS Lett 1987, 220:159-162.
42. Sirtori CR, Calabresi L, Ferrara S, Pazzucconi F, Bondioli A, Baldassarre D, Birreci A, Koverech A: L-Carnitine reduces plasma lipoprotein(a) levels in patients with hyper Lp(a). Nutr Metab Cardiovasc Dis 2000, 10:247-251.
43. Derosa G, Cicero FGA, Gaddi A, Mugellini A, Ciccarelli L, Fogari R: The effect of L-carnitine on plasma lipoprotein(a) levels in hypercholesterolemic patients with type 2 diabetes mellitus. Clin Ther 2003, 25:1429-1439.
44. Rahbar AR, Shakerhosseini R, Saadat N, Taleban F, Pordal A, Gollestan B: Effect of L-carnitine on plasma glycemic and lipidemic profile in patients with type II diabetes mellitus. Eur J Clin Nutr 2005, 59:592-596.
45. Marczuk-Krynicka D, Hryniewiecki T, Piatek J, Paluszak J: The effect of brief food withdrawal on the level of free radicals and other parameters of oxidative status in the liver. Med Sci Monit 2003, 9:BR131-BR135.
46. Sorensen M, Sanz A, Gómez J, Pamplona R, Portero-Otín M, Gredilla R, Barja G: Effects of fasting on oxidative stress in rat liver mitochondria. Free Radic Res 2006, 40:339-347.
47. Dobrzynska I, Szachowicz-Petelska B, Skrzydlewska E, Figaszewski Z: Effect of L-carnitine on liver cell membranes in ethanol-intoxicated rats. Chem Biol Interact 2010, 188:44-51.
48. Lee DH, Blomhoff R, Jacobs DR Jr: Is serum gamma glutamyltransferase a marker of oxidative stress? Free Radic Res 2004, 38:535-539.
49. Lennox WG: Increase of uric acid in the blood during prolonged starvation. JAMA 1924, 82:602.
50. Ogryzlo MA: Hyperuricemia induced by high fat diets and starvation. Arthritis Rheum 1965, 8:799-822.
51. Robin JP, Boucontet L, Chillet P, Groscolas R: Behavioral change in fasting emoperor penguins:evidence for a "refeeding signal" linked to a metabolic shift. Am J Physiol 1998, 274:R746-R753.